Turnover
≈ €270,000 estimated
The micro format states no turnover.
SRGDR
Overview
Lifetime
1 annual account with figurespeak €133,209 (2025)
€133,209
peak €88,376 (2025)
€88,376
peak €89,543 (2025)
€89,543
€15,910
Board1 name since 2024
1 directorROGISTER Sandrine Béatrice Erika
Documentsfilings and deeds
26-06-202635 days before the deadline
2025micro format
Dividend €833First year with figures
Key points
from the 2025 annual accountsChecked score
98
Excellent
Financially stronger than 82% of micro companies in human health (NACE 86)
Probability in this band: under 0.55%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%
The dashed line is the sector median: < 0.1% across 24,185 companies (NACE 86, micro).
Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
10-2025: 0.3%
11-2025: 0.3%● unchanged vs 10-2025
12-2025: 0.3%● unchanged vs 11-2025
01-2026: 0.3%● unchanged vs 12-2025
02-2026: 0.3%● unchanged vs 01-2026
03-2026: 0.3%● unchanged vs 02-2026
04-2026: 0.4%▲ +0.1 percentage points vs 03-2026
05-2026: 0.4%● unchanged vs 04-2026
06-2026: 0.4%● unchanged vs 05-2026
07-2026: 0.4%● unchanged vs 06-2026
08-2026: 0.4%● unchanged vs 07-2026
09-2026: 0.4%● unchanged vs 08-2026highest value
10-2026: < 0.1%▼ -0.4 percentage points vs 09-2026lowest value
11-2026: < 0.1%● unchanged vs 10-2026lowest value
Financial strengthStrong
Score breakdown
raises risk
Founded in 2024
lowers risk
Sector: Human health activities (NACE 86)
Liquidity: current ratio 5.12, cash €67,980
Equity €89,543 (84.9% of total assets)
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 82% of them on solvency, 85% on liquidity and 80% on profitability.
The bankruptcy probability was computed on 09-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
The probability rests on the annual accounts with balance sheet date 31-12-2025.
Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Comparable companies, two years later
In July 2024, 39,278 companies had the same profile as SRGDR has now. Each dot stands for 99 companies, two years later.
95.8%
were still trading
2.3%
stopped another way
1.8%
went bankrupt
Another 0.1% stopped without a precise date, possibly only after those two years.
The bankruptcy probability of SRGDR itself is lower: < 0.1% within 12 months. It rests on far more data about SRGDR than the profile alone.
Test of the method
The method was tested on the 497,447 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 39,278 companies, not a prediction for SRGDR. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit of up to €8,000 on 30-day terms, only on tighter conditions: young company (under 3 years) without a track record
Liquidity is ample, with a current ratio of 5.12, above the usual 1.5. Short-term debt is 15.1% and cash 64.5% of total assets. 15.1% of the assets are financed with debt and provisions.
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Five signals.
lowers riskraises riskneutral
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 26-06-2026, 35 days ahead of the deadline.
NBB · 1 filingDeviation from the deadline
2025
35 days early
← before the deadline
after the deadline →
Searched, nothing found (1)
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:1013370282
Incorporation
Founding capital of €2,000, 1,000 shares · Founder: ROGISTER Sandrine Béatrice Erika · Appointment: ROGISTER Sandrine Béatrice Erika (director) · published on 12-09-2024 · Gazette deed
First establishment
Rue Bureau 72, Fléron
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| SRGDR Fléron | €105,453 | €133,209 | 84.9% | - |
| DRMA Turnhout | €111,770 | €138,160 | 86.2% | - |
| JDV algemene geneeskunde Overijse | €92,788 | €121,791 | 98.2% | - |
| Loumed Steenokkerzeel | €126,653 | €133,194 | 79.3% | - |
| Dr ALINE WAGELMANS Sprimont | €135,777 | €120,288 | 81.9% | - |
| Dr MARTIAL Blegny | €127,307 | €107,922 | 65.1% | - |
| Dizier Marjolaine Rochefort | €91,031 | €132,653 | 91.1% | - |
These companies have the same main activity as SRGDR: general medical practice (NACE 86210). They are comparable in size and age: total assets between €91,000 and €136,000, founded between 2024 and 2025.
Official details
Source: KBO- Status
- Active since 10-09-2024Normal situation
- Registered office
- 14 active companies are registered at this addressSource: KBO register, as of 10 November 2026.
- Activity
- General medical practiceNACE 86210
- Establishment unit
- 2.363.792.3074621 Fléron, since 10-09-2024
- Financial year end
- 31 December
- Peppol
- Reachable since 27-03-2026
Annual accounts 2025
- €133,209
- €88,376
- €89,543
- €105,453
- Filing
- Filed on 26-06-2026, 35 days before the end of the filing period
Insights on SRGDR
SRGDR has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €89,543 and a net result of €88,376.
Its solvency ranks better than 77% of 20,767 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
Sources: KBO register, filings at the National Bank, Belgian Official Gazette.
Financials
Annual accounts 2025
micro format, filed on 26-06-2026, 35 days before the deadline€133,209
€125,450
€88,376
€65,625
84.9%
5.12
Turnover and EBIT margin are not published. The micro format does not require them. The turnover shown is an estimate from the gross margin.
Turnover ≈ €270,000. Estimated: probably between €200,000 and €330,000.
Balance sheet
balance sheet total €105,453 on 31-12-2025What the company ownsHow it is paid for
Position in the sector
84.9%
Higher than 77% of 20,767 companies in 2025.
5.12
Higher than 69% of 20,341 companies in 2025.
83.8%
Higher than 95% of 20,623 companies in 2025.
SRGDR
Middle half of the sector
80% of the sector
Micro accounts in human health (NACE 86)
Net result: middle half · Equity: middle half · Balance sheet total: bottom quarter · Working capital: middle half
Filed annual accounts
as filed with the National Bank, click a year to choose it| Line | Trend | 2025 |
|---|---|---|
| Balance sheet: assets | ||
20/58 |
105,453 | |
21/28 |
23,918 | |
22/27 |
23,918 | |
24 |
23,918 | |
29/58 |
81,535 | |
40/41 |
418 | |
40 |
418 | |
54/58 |
67,980 | |
490/1 |
13,137 | |
| Balance sheet: equity and liabilities | ||
10/49 |
105,453 | |
10/15 |
89,543 | |
10/11 |
2,000 | |
13 |
87,543 | |
133 |
87,543 | |
17/49 |
15,910 | |
42/48 |
15,910 | |
44 |
388 | |
440/4 |
388 | |
45 |
14,285 | |
450/3 |
14,285 | |
47/48 |
1,237 | |
| Income statement | ||
9900 |
133,209 | |
630 |
6,633 | |
640/8 |
1,127 | |
9901 |
125,450 | |
65/66B |
88 | |
65 |
88 | |
9903 |
125,362 | |
67/77 |
36,986 | |
9904 |
88,376 | |
9905 |
88,376 | |
| Appropriation of the result | ||
9906 |
88,376 | |
691/2 |
87,543 | |
6921 |
87,543 | |
694/7 |
833 | |
694 |
833 | |
| Document | ||
The notes to these accounts have 6 items, including the statement of assets and debts, the cost breakdown and rights and commitments. You find them in the accounts filed with the NBB.
Source: Annual accounts 2025 at the NBB, filed on 26-06-2026.
Filings
each dot is a set of accounts, on the day it reached the National Bank| Financial year | Type | Filed | Reference | Document |
|---|---|---|---|---|
| 31-12-2025 | micro format | 26-06-2026 | 2026-00227433 |
Key figures and ratios
per financial year, computed from the annual accounts| Line | Trend | 2025 |
|---|---|---|
| 132,083 | ||
| 95,009 | ||
| 31,901 | ||
| 65,625 | ||
| 84.9% | ||
| 5.12 | ||
| 0.18 | ||
| 98.7% | ||
| 83.8% | ||
| over 100 |
A Belgian filing has no cash-flow statement. Cash flow is therefore an approximation, derived from the income statement. Investment is the acquisitions in the notes and, without them, the balance-sheet move.
Investments
fixed assets acquired| Item | 2025 |
|---|---|
| Tangible fixed assets | €31,901 |
| €6,633 |
Source: notes to the 2025 annual accounts (statement of fixed assets)
Insights on SRGDR
Debt's share of the balance-sheet total is 15.1%.
Board & ownership
Board
1 director, since incorporationDirector (not named in the articles)
since 05-09-2024
term without a fixed end
listed in the 2025 annual accounts, filed on 26-06-2026
- Signing authorityThe articles say who may bind the company, for example by signing a contract.
- “Article 15. Représentation Tous les actes engageant la société, autres que ceux de gestion journalière, même les actes auxquels un…”deed of 12-09-2024
Mandates through the years
1 name, the dashed line is todayROGISTER Sandrine Béatrice Erika
Director (not named in the articles)
Director (not named in the articles)
Board
Mandates as a list
- ROGISTER Sandrine Béatrice Erika
- Director (not named in the articles), from 05-09-2024 to date
Control
Capital
- Contribution
- €2,000
- Shares
- 1,000
- Contribution per share
- €2
- Equity per share
- €89.54 in 2025
- Source
- deed of 12-09-2024
Articles of association
deed of 12-09-2024 (in French)- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimited
- Board ruleThese rules set how the board is made up, meets and takes decisions.
- “Révocation administrateur, conditions majorité et présence modifications statuts”
- Statutory auditorA statutory auditor is a registered auditor who checks the annual accounts. Small companies need not have one. According to the deed, the legal criteria do not require one here.
- No statutory auditor
Shareholders
At incorporation
deed of 12-09-2024 ↗
- ROGISTER Sandrine Béatrice Erika 1,000 shares (100%) · €2,000 in cash
Network & group
No group
SRGDR has no parent and no holdings in its annual accounts. ROGISTER Sandrine Béatrice Erika is the only director. SRGDR shares no director with another company.
At the same address
Rue Bureau 72, 4621 Fléron · 13 other companies| Le Bureau Médical
registered office since 23-12-1989 · founded in 1989 |
total assets €1.5m (2025) 0439.642.996 |
| IMMOBILIERE BUREAU MEDICAL
registered office since 21-10-2015 · founded in 2015 |
total assets €351,913 (2025) 0641.751.406 |
| MEDECINE ET DEVELOPPEMENTS
establishment since 23-10-2020 · founded in 2020 |
total assets €205,602 (2025) 0756.920.494 |
| Docteur Christelle LAMBIET
establishment since 20-12-2021 · founded in 2021 |
total assets €130,666 (2025) 0778.863.676 |
| DRFRH
establishment since 23-09-2025 |
founded in 2025 1028.026.784 |
| Burgio, Luca (sole trader)
establishment since 04-10-2021 |
founded in 2021 0774.878.164 |
| Bastin, Annie (sole trader)
establishment since 01-10-2021 |
founded in 2021 0773.995.563 |
| Lambiet, Christelle (sole trader)
establishment since 01-10-2020 |
founded in 2020 0754.386.816 |
| Rodrigues Castelli, Andressa (sole trader)
establishment since 01-10-2019 |
founded in 2019 0736.395.096 |
| Nicolet, Delphine (sole trader)
establishment since 20-05-2015 |
founded in 2015 0630.737.253 |
Timeline
Timeline
4 events since 2024Filings
Establishments
202420252026
2026
Annual accounts 2025 filed NBBmicro format · 35 days before the deadline
Registered in the Peppol Directory Reachable for e-invoices through 0208:1013370282
2024
IncorporationFounding capital of €2,000, 1,000 shares · Founder: ROGISTER Sandrine Béatrice Erika · Appointment: ROGISTER Sandrine Béatrice Erika (director) · published on 12-09-20247 points ▸
- Registered office clause, Rue Bureau 72, 4621 Retinne
- Board rule, 1
- Director appointment, ROGISTER Sandrine Béatrice Erika (director (not named in the articles))
- Power of attorney, ROGISTER Sandrine Béatrice Erika (proxy holder)
- Power of attorney, Véronique SMETS
- Founder, ROGISTER Sandrine Béatrice Erika
- Founding capital, €2,000, 1,000 shares
- The deed holds 5 more points.
First establishment Rue Bureau 72, Fléron
Sources: Publications in the Belgian Official GazetteFilings with the National Bank
Company details
Identity
- Enterprise number
- 1013.370.282
- VAT number
- BE 1013.370.282
- Peppol ID
- 0208:1013370282
- Other Peppol ID
- 9925:BE1013370282
- Legal form
- Private limited company
- Status
- Active, normal situation
- Founded
- 10-09-2024
- Financial year
- ends on 31 December
- Peppol
- Reachable since 27-03-2026Follow this company and you will hear the next morning if it leaves the Peppol register.
- Name
- SRGDR in French
- Entity type
- Legal entity
- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimiteddeed of 12-09-2024 (in French)
Activities
NACEBEL 202586210
General medical practice main activity
- PurposeThe purpose describes the activities the company may carry out under its articles.
- “Exploitation commerciale de la médecine; Collusion directe ou indirecte; Dichotomie; Surconsommation”deed of 12-09-2024 (in French)
4 activities
- Exploitation commerciale de la médecine
- Collusion directe ou indirecte
- Dichotomie
- Surconsommation
Registered office and establishments
1 establishment| Establishment | Since | Unit number |
|---|---|---|
| Rue Bureau 72 registered office 4621 Fléron | 10-09-2024 | 2.363.792.307 |
Buildings and parcels at the address
- Ground area
- 269 m²
- Buildings
- 80 m²
- Volume, LiDAR
- 588 m³
- Tallest building
- 8.6 m
Buildings to scale, each on its own parcel
Parcels
| Cadastral parcel | Area | Buildings | Height / floors |
|---|---|---|---|
| 62084C0210/00Y000 | 269 m² | 1 · 80 m² | 8.6 m · 2 |